| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.07 |